Literature DB >> 25083467

Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: research highlight.

Rachel L O'Connell1, Jennifer E Rusby1.   

Abstract

The rate of surgical site infection (SSI) after breast surgery is higher than expected for a 'clean procedure'. There is currently no consensus on the use of antibiotics, and as a result there is variation in use. An infection may compromise cosmesis and delay the start of adjuvant therapy. This research highlight reviews a recent paper by Gulluoglu and colleagues investigating the use of antibiotics in overweight and obese patients undergoing breast cancer surgery and also reviews the current literature on this important topic.

Entities:  

Keywords:  Surgical site infection (SSI); breast cancer surgery

Year:  2013        PMID: 25083467      PMCID: PMC4115739          DOI: 10.3978/j.issn.2227-684X.2013.05.07

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  20 in total

1.  Current use of antibiotic prophylaxis in breast surgery: a nationwide survey.

Authors:  Darren Ng; Prateesh M Trivedi; Anup K Sharma; Dibyesh Banerjee
Journal:  Breast       Date:  2006-08-02       Impact factor: 4.380

2.  An updated meta-analysis on the effectiveness of preoperative prophylactic antibiotics in patients undergoing breast surgical procedures.

Authors:  Muhammad S Sajid; Kristian Hutson; Naved Akhter; Lorain Kalra; Ignacio F Rapisarda; Ricardo Bonomi
Journal:  Breast J       Date:  2012-05-23       Impact factor: 2.431

3.  National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009.

Authors:  Jonathan R Edwards; Kelly D Peterson; Yi Mu; Shailendra Banerjee; Katherine Allen-Bridson; Gloria Morrell; Margaret A Dudeck; Daniel A Pollock; Teresa C Horan
Journal:  Am J Infect Control       Date:  2009-12       Impact factor: 2.918

4.  A prospective analysis of nosocomial wound infection after mastectomy.

Authors:  J D Beatty; G V Robinson; J A Zaia; J R Benfield; M M Kemeny; M M Meguid; D U Riihimaki; J J Terz; M E Lemmelin
Journal:  Arch Surg       Date:  1983-12

5.  Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: A case-control analysis.

Authors:  Eva Ruvalcaba-Limón; Carlos Robles-Vidal; Adela Poitevin-Chacón; Mariana Chávez-Macgregor; Carlos Gamboa-Vignolle; Diana Vilar-Compte
Journal:  Breast Cancer Res Treat       Date:  2005-12-01       Impact factor: 4.872

6.  Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial.

Authors:  Bahadir M Gulluoglu; Sertac Ata Guler; M Umit Ugurlu; Gulcan Culha
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

7.  Risk factors for surgical site infection in breast surgery.

Authors:  Aholaakko Teija-Kaisa; Metsälä Eija; Sihvonen Marja; Lyytikäinen Outi
Journal:  J Clin Nurs       Date:  2012-11-02       Impact factor: 3.036

8.  Risk factors for surgical site infection after major breast operation.

Authors:  Margaret A Olsen; Mellani Lefta; Jill R Dietz; Keith E Brandt; Rebecca Aft; Ryan Matthews; Jennie Mayfield; Victoria J Fraser
Journal:  J Am Coll Surg       Date:  2008-06-26       Impact factor: 6.113

9.  Infectious complications following breast reconstruction with expanders and implants.

Authors:  Maurice Y Nahabedian; Theodore Tsangaris; Bahram Momen; Paul N Manson
Journal:  Plast Reconstr Surg       Date:  2003-08       Impact factor: 4.730

10.  Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon; Mauricio Tawil; Lilian Torregrosa
Journal:  BMC Surg       Date:  2012-08-31       Impact factor: 2.102

View more
  1 in total

1.  Tumor-Targeted Injectable Double-Network Hydrogel for Prevention of Breast Cancer Recurrence and Wound Infection via Synergistic Photothermal and Brachytherapy.

Authors:  Yuanhao Wu; Yuan Yao; Jiamin Zhang; Han Gui; Jinjian Liu; Jianfeng Liu
Journal:  Adv Sci (Weinh)       Date:  2022-06-25       Impact factor: 17.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.